STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

MEMORIAL SLOAN-KETTERING CANCER CENTER: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236)
Tax period
2021-01-01 to 2021-12-31
Filed
2022-11-11
IRS object ID
202223159349302707
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-11-11T10:12:27-06:00ReturnTs
Tax Period End2021-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1111 MONUMENT CIRCLEAddressLine1Txt
CityINDIANAPOLISCityNm
State AbbreviationINStateAbbreviationCd
ZIP46204ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN131924236EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Memorial Sloan-Kettering Cancer CenterBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% MARK K SVENNINGSONInCareOfNm
Business Name ControlMEMOBusinessNameControlTxt
Phone6462273092PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11275 YORK AVENUEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100656007ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonMARK K SVENNINGSONPersonNm
Person TitleSVP FINANCEPersonTitleTxt
Phone6462273092PhoneNum
Signature2022-11-10SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstMARK KPersonFirstNm
Person LastSVENNINGSONPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJENNIFER D RHODERICKPreparerPersonNm
PTINP00395735PTIN
Phone3176817000PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerSELWYN M VICKERS MDPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11275 YORK AVENUEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100656007ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$2,103,389,743GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Group Exemption3475GroupExemptionNum
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.MSKCC.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1960FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionLEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATIONActivityOrMissionDesc
Voting Members Governing Body31VotingMembersGoverningBodyCnt
Voting Members Independent30VotingMembersIndependentCnt
Total Employee29732TotalEmployeeCnt
Total Volunteers262TotalVolunteersCnt
Total Gross UBI$7,147,496TotalGrossUBIAmt
PY Contributions Grants$42,290,773PYContributionsGrantsAmt
CY Contributions Grants$257,200,000CYContributionsGrantsAmt
PY Program Service Revenue$897,928,000PYProgramServiceRevenueAmt
CY Program Service Revenue$1,053,813,000CYProgramServiceRevenueAmt
PY Investment Income$132,556,000PYInvestmentIncomeAmt
CY Investment Income$210,943,000CYInvestmentIncomeAmt
PY Other Revenue$39,249,001PYOtherRevenueAmt
CY Other Revenue$29,465,000CYOtherRevenueAmt
PY Total Revenue$1,112,023,774PYTotalRevenueAmt
CY Total Revenue$1,551,421,000CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$585,073,238PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$686,762,230CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$71,894,554CYTotalFundraisingExpenseAmt
PY Other Expenses$546,406,536PYOtherExpensesAmt
CY Other Expenses$570,218,420CYOtherExpensesAmt
PY Total Expenses$1,131,479,774PYTotalExpensesAmt
CY Total Expenses$1,256,980,650CYTotalExpensesAmt
PY Revenues Less Expenses-$19,456,000PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$294,440,350CYRevenuesLessExpensesAmt
Total Assets BOY$6,797,163,000TotalAssetsBOYAmt
Total Assets EOY$8,128,780,000TotalAssetsEOYAmt
Total Liabilities BOY$3,643,290,000TotalLiabilitiesBOYAmt
Total Liabilities EOY$3,959,968,000TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$3,153,873,000NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$4,168,812,000NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionMEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$1,094,895,570ExpenseAmt
Grant$0GrantAmt
Revenue$1,050,200,000RevenueAmt
DescMEMORIAL SLOAN-KETTERING CANCER CENTER PROVIDES THE FOLLOWING SERVICES TO ITS AFFILIATED ORGANIZATIONS: FINANCIAL ADMINISTRATION, EXECUTIVE MANAGEMENT, HUMAN RESOURCES, FACILITY MANAGEMENT, GENERAL AND ENVIRONMENTAL SERVICES, PROCUREMENT, PUBLIC AFFAIRS, RESEARCH TECHNOLOGY MANAGEMENT, CORPORATE COMPLIANCE, INFORMATION SYSTEMS AND TECHNOLOGY, AND INVESTMENT MANAGEMENT. IN ADDITION, CERTAIN SERVICES ARE PROVIDED ON A REQUISITION BASIS INCLUDING FOOD AND DIETARY SERVICES, FACILITIES MANAGEMENT (LOCKSMITH, ELECTRICIAN, PLUMBING, PAINTING AND CARPENTRY, ETC.) MEDICAL LIBRARY, CONFERENCE PLANNING, OCCUPANCY OF LEASED SPACE, TRANSPORTATION, IMMIGRATION SERVICES, MEDICAL ILLUSTRATION, MOTION MEDIA, SECURITY SERVICES SUCH AS INSTALLING ANTI-THEFT DEVICES AND MAILROOM SERVICES.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$19,845,312ExpenseAmt
Grant$0GrantAmt
Revenue$18,527,000RevenueAmt
DescCAFETERIA: THE CENTER OPERATES A CAFETERIA IN THE MAIN BUILDING COMPLEX WHERE VISITORS AND PATIENTS CAN PURCHASE MEALS AND SNACKS. SOCIETY OF MSKCC: THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER, FOUNDED IN 1946, IS A VOLUNTEER ORGANIZATION DEDICATED TO PROMOTING THE WELL-BEING OF PATIENTS, SUPPORTING CANCER RESEARCH AND PROVIDING PUBLIC EDUCATION ON THE PREVENTION, EARLY DETECTION AND TREATMENT OF CANCER. PROSTATE CANCER CLINICAL TRIALS CONSORTIUM, LLC. (PCCTC): THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM (PCCTC) WAS INITIATED IN 2005 BY THE PROSTATE CANCER FOUNDATION (PCF) AND THE U.S. DEPARTMENT OF DEFENSE (DOD) PROSTATE CANCER RESEARCH PROGRAM (PCRP). ESTABLISHED AS AN INDEPENDENT ENTITY IN 2014, THE PCCTC, LLC IS NOW THE NATION'S PREMIER MULTICENTER CLINICAL RESEARCH ORGANIZATION SPECIALIZING IN CUTTING-EDGE PROSTATE CANCER RESEARCH. MSK IS THE SINGLE MEMBER OF THE PCCTC, WHO HAS ELECTED TO BE TREATED AS A DISREGARDED ENTITY OF MSK FOR TAX PURPOSES. THE COSTS SHOWN HERE FOR THE ABOVE PROGRAMS, ARE EXCLUSIVE OF FUNDRAISING ACTIVITIES, WHICH ARE REPORTED IN PART IX, COLUMN D. EXPENSES REVENUE CAFETERIA $ 4,362,921 $ 3,613,000 SOCIETY $ 2,624,067 $ 0 PCCTC $12,858,324 $14,914,000 TOTAL $19,845,312 $18,527,000Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$12,116,760ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescMSKCC PAYS FEES TO CORNELL MEDICAL CENTER AND OTHER MEDICAL INSTITUTIONS FOR STAFF TO FURTHER THEIR SCIENTIFIC EDUCATION. IN ADDITION, THE CENTER HOSTS A NUMBER OF SYMPOSIUMS, SOME OF WHICH ARE OPEN TO THE PUBLIC.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$0TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$1,126,857,642TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnotefalseIncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsYes (true)TaxExemptBondsInd
Invest Tax Exempt BondsfalseInvestTaxExemptBondsInd
Escrow AccountfalseEscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityYes (true)DisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (true)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document1329IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee29732EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (true)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members31GoverningBodyVotingMembersCnt
Independent Voting Member30IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyfalseForm990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VentureYes (true)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (true)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldIDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldIAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPRStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTXStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWYStatesWhereCopyOfReturnIsFldCd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonMARK K SVENNINGSONPersonNm
Phone6462273414PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1633 THIRD AVENUEAddressLine1Txt
CityNew YorkCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10017ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (51 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
CRAIG P THOMPSON MD
BOARD MBR, PRESIDENT & CEO50.00.0Yes (X)Yes (X)$2,684,526$0$280,957
JASON KLEIN
SVP & CHIEF INVESTMENT OFFICER50.00.0Yes (X)$2,731,258$0$87,025
KATHRYN MARTIN
EVP & COO50.00.0Yes (X)$1,760,489$0$85,572
MICHAEL HARRINGTON
evp & CFO50.00.0Yes (X)$1,774,641$0$63,339
PHILIP KANTOFF
VISITING INVESTIGATOR50.00.0$1,484,778$0$47,755Yes (X)
JORGE LOPEZ ESQ
EVP & GENERAL COUNCEL50.00.0Yes (X)$1,307,132$0$80,359
KERRY BESSEY
SVP & CHIEF HR OFFICER50.00.0Yes (X)$1,260,979$0$81,357
KENNETH MANOTTI
SVP DEVELOPMENT50.00.0Yes (X)$1,250,637$0$67,241
GREGORY RASKIN
VP, TECHNOLOGY DEVELOPMENT50.00.0$1,142,149$0$74,487Yes (X)
ROXANNE TAYLOR
CHIEF MARKET & COMM. OFFICER50.00.0Yes (X)$1,149,642$0$38,174
WENDY PERCHICK
SVP STRATEGIC PLANNING & INNOV50.00.0$1,018,805$0$70,069Yes (X)
DEBRA BERNS ESQ
SVP & CHIEF RISK OFFICER50.00.0Yes (X)$987,455$0$48,303
ERIC M COTTINGTON PHD
SVP, RESEARCH & TECH MGMT50.00.0Yes (X)$950,138$0$73,969
LARRY NORTON
SVP OFFICE OF THE PRESIDE/CEO50.00.0$939,686$0$81,451Yes (X)
ATEFEH RIAZI
CHIEF INFORMATION OFFICER50.00.0$968,348$0$34,436Yes (X)
MARK SVENNINGSON
SVP FINANCE50.00.0Yes (X)$850,147$0$73,017
EDWARD MAHONEY
SVP, FACILITIES MGMT & CONST50.00.0Yes (X)$837,621$0$49,785
CLAUS JENSEN
EVP & CHIEF DIGITAL OFFICER50.00.0Yes (X)$688,368$0$43,434
CAROLYN LEVINE ESQ
DEPUTY GEN COUNSEL CORP SECTY50.00.0Yes (X)$541,368$0$58,986
PATRICIA C SKARULIS
FORMER SVP CIO until 12/20190.00.0$377,770$0$6,521Yes (X)
AVICE MEEHAN
FORMER SVP CCO until 5/20190.00.0$198,979$0$11,714Yes (X)
RICHARD I BEATTIE
BOARD MEMBER1.00.0Yes (X)$0$0$0
IAN COOK
BOARD MEMBER1.00.0Yes (X)$0$0$0
STANLEY F DRUCKENMILLER
BOARD MEMBER1.00.0Yes (X)$0$0$0
ANTHONY B EVNIN
BOARD MEMBER1.00.0Yes (X)$0$0$0
ROGER W FERGUSON
BOARD MEMBER1.00.0Yes (X)$0$0$0
WILLIAM E FORD
BOARD MEMBER1.00.0Yes (X)$0$0$0
RICHARD N FOSTER
BOARD MEMBER1.00.0Yes (X)$0$0$0
STEPHEN FRIEDMAN
BOARD MEMBER1.00.0Yes (X)$0$0$0
ELLEN V FUTTER
BOARD MEMBER1.00.0Yes (X)$0$0$0
LOUIS V GERSTNER JR
BOARD MEMBER1.00.0Yes (X)$0$0$0
JONATHAN N GRAYER
BOARD MEMBER1.00.0Yes (X)$0$0$0
BENJAMIN W HEINEMAN JR
BOARD MEMBER1.00.0Yes (X)$0$0$0
MARIE-JOSEE KRAVIS
VICE CHAIR OF THE BOARD2.00.0Yes (X)$0$0$0
JAMIE C NICHOLLS
VICE CHAIR OF THE BOARD2.00.0Yes (X)$0$0$0
JAMES G NIVEN
BOARD MEMBER1.00.0Yes (X)$0$0$0
BRUCE C RATNER
BOARD MEMBER1.00.0Yes (X)$0$0$0
ALEXANDER T ROBERTSON
BOARD MEMBER1.00.0Yes (X)$0$0$0
JAMES D ROBINSON III
BOARD MEMBER1.00.0Yes (X)$0$0$0
VIRGINIA M ROMETTY
BOARD MEMBER1.00.0Yes (X)$0$0$0
PETER J SOLOMON
BOARD MEMBER1.00.0Yes (X)$0$0$0
JOHN R STRANGFELD
BOARD MEMBER1.00.0Yes (X)$0$0$0
PETER A WEINBERG
BOARD MEMBER & SECRETARY2.00.0Yes (X)$0$0$0
SCOTT M STUART
CHAIR OF THE BOARD2.00.0Yes (X)$0$0$0
CLIFTON S ROBBINS
BOARD MEMBER & TREASURER2.00.0Yes (X)Yes (X)$0$0$0
DOUGLAS A WARNER III
HONORARY CHAIR OF THE BOARD2.00.0Yes (X)Yes (X)$0$0$0
HENRY A FERNANDEZ
BOARD MEMBER1.00.0Yes (X)$0$0$0
ALAN D SCHNITZER
BOARD MEMBER1.00.0Yes (X)$0$0$0
WILLIAM HELMAN
BOARD MEMBER1.00.0Yes (X)$0$0$0
MARGARET KEANE
BOARD MEMBER1.00.0Yes (X)$0$0$0
STEPHEN C SHERRILL
BOARD MEMBER1.00.0Yes (X)$0$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$24,904,916TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$1,457,951TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K1861IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
TURNER CONSTRUCTION
375 HUDSON STREETNEW YORKNY10014GENERAL CONSTRUCTION$31,623,606
ACCENTURE LLP
1345 AVENUE OF THE AMERICASNEW YORKNY10105CONSULTING$10,486,074
JGN CONSTRUCTION CORP
66-40 69TH STREETMIDDLE VILLAGENY11379GENERAL CONSTRUCTION$10,146,701
LEND LEASE US CONSTRUCTION
200 PARK AVENUENEW YORKNY10166GENERAL CONSTRUCTION$8,221,785
MICHAEL ANTHONY CONTRACTING
161 RAILROAD AVENUENEW HYDE PARKNY11040GENERAL CONSTRUCTION$5,129,938
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K161CntrctRcvdGreaterThan100KCnt
All Other Contributions$257,200,000AllOtherContributionsAmt
Noncash Contributions$1,726,828NoncashContributionsAmt
Total Contributions$257,200,000TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
SERVICES PROVIDED SEE NOTE A & ATTACH.1 IN SCH O900099$1,050,200,000$1,050,200,000
CAFETERIA721000$3,613,000$3,613,000
FieldValueIRS element (for citing)
Total Program Service Revenue$1,053,813,000TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,111,000TotalRevenueColumnAmt
Unrelated Business Revenue$7,147,496UnrelatedBusinessRevenueAmt
Exclusion$2,963,504ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$30,000TotalRevenueColumnAmt
Exclusion$30,000ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$752,800,743SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$551,968,743SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$200,832,000SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$200,832,000TotalRevenueColumnAmt
Exclusion$200,832,000ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Fundraising Direct Expenses$0FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
RESEARCH EXPENSE RECOVERY711110$14,914,000$14,914,000
GIFT SHOP INCOME811000$1,542,000$1,542,000
VENDOR DISCOUNT900099$1,012,000$1,012,000

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$11,967,000TotalRevenueColumnAmt
Exclusion$11,967,000ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$29,435,000OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,551,421,000TotalRevenueColumnAmt
Related Or Exempt Func Income$1,068,727,000RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$7,147,496UnrelatedBusinessRevenueAmt
Exclusion$218,346,504ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$19,905,919TotalAmt
Program Services$14,773,817ProgramServicesAmt
Management And General$3,762,293ManagementAndGeneralAmt
Fundraising$1,369,809FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$594,984TotalAmt
Program Services$488,023ProgramServicesAmt
Management And General$106,000ManagementAndGeneralAmt
Fundraising$961FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$507,372,455TotalAmt
Program Services$466,915,672ProgramServicesAmt
Management And General$10,535,293ManagementAndGeneralAmt
Fundraising$29,921,490FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$38,878,093TotalAmt
Program Services$35,520,634ProgramServicesAmt
Management And General$1,608,793ManagementAndGeneralAmt
Fundraising$1,748,666FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$83,118,001TotalAmt
Program Services$77,329,922ProgramServicesAmt
Management And General$14,176ManagementAndGeneralAmt
Fundraising$5,773,903FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$36,892,778TotalAmt
Program Services$33,706,768ProgramServicesAmt
Management And General$1,510,126ManagementAndGeneralAmt
Fundraising$1,675,884FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$13,374,098TotalAmt
Program Services$12,717,901ProgramServicesAmt
Management And General$652,771ManagementAndGeneralAmt
Fundraising$3,426FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$1,138,833TotalAmt
Program Services$1,119,936ProgramServicesAmt
Management And General$18,208ManagementAndGeneralAmt
Fundraising$689FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$540,244TotalAmt
Program Services$540,244ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$9,337,887TotalAmt
Management And General$9,337,887ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$64,342,581TotalAmt
Program Services$50,873,266ProgramServicesAmt
Management And General$6,062,472ManagementAndGeneralAmt
Fundraising$7,406,843FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$34,652,604TotalAmt
Program Services$32,619,027ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$2,033,577FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$155,445,613TotalAmt
Program Services$129,297,230ProgramServicesAmt
Management And General$9,520,758ManagementAndGeneralAmt
Fundraising$16,627,625FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$91,265,211TotalAmt
Program Services$89,636,234ProgramServicesAmt
Management And General$415,120ManagementAndGeneralAmt
Fundraising$1,213,857FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$29,449,596TotalAmt
Program Services$28,672,368ProgramServicesAmt
Management And General$656,777ManagementAndGeneralAmt
Fundraising$120,451FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$224,401TotalAmt
Program Services$195,699ProgramServicesAmt
Management And General$1,628ManagementAndGeneralAmt
Fundraising$27,074FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$1,884,023TotalAmt
Program Services$1,808,466ProgramServicesAmt
Management And General$21,859ManagementAndGeneralAmt
Fundraising$53,698FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$18,207,554TotalAmt
Program Services$6,123,398ProgramServicesAmt
Management And General$12,084,156ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$93,050,695TotalAmt
Program Services$92,431,130ProgramServicesAmt
Management And General$132,458ManagementAndGeneralAmt
Fundraising$487,107FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$2,578,567TotalAmt
Program Services$2,419,944ProgramServicesAmt
Management And General$24,678ManagementAndGeneralAmt
Fundraising$133,945FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
NET REQUISITIONED SERVICES$34,709,868$29,710,014$1,709,190$3,290,664
MED/SURG SUPPLIES$6,662,833$6,659,907$2,424$502
UBIT EXPENSE$50,576$50,576
PHARMACEUTICALS$444,913$439,719$811$4,383

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$12,858,323TotalAmt
Program Services$13,297,950ProgramServicesAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$1,256,980,650TotalAmt
Program Services$1,126,857,642ProgramServicesAmt
Management And General$58,228,454ManagementAndGeneralAmt
Fundraising$71,894,554FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$15,573,219TotalAmt
Program Services$5,642,489ProgramServicesAmt
Fundraising$9,930,730FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$329,227,000BOYAmt
EOY$155,009,000EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$818,066,000BOYAmt
EOY$1,040,648,000EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$70,767,000BOYAmt
EOY$168,331,000EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$145,070,000BOYAmt
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$47,269,000BOYAmt
EOY$55,117,000EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$624,000BOYAmt
EOY$3,248,000EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$141,356,000BOYAmt
EOY$327,165,000EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,529,154,000LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$770,263,000LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$609,800,000BOYAmt
EOY$758,891,000EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$3,186,062,000BOYAmt
EOY$3,652,595,000EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$1,448,922,000BOYAmt
EOY$1,967,776,000EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$6,797,163,000BOYAmt
EOY$8,128,780,000EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$509,931,000BOYAmt
EOY$568,953,000EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,615,976,000BOYAmt
EOY$1,651,455,000EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$1,381,956,000BOYAmt
EOY$1,350,000,000EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$135,427,000BOYAmt
EOY$389,560,000EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,643,290,000BOYAmt
EOY$3,959,968,000EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,829,703,000BOYAmt
EOY$3,726,253,000EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$324,170,000BOYAmt
EOY$442,559,000EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$3,153,873,000BOYAmt
EOY$4,168,812,000EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$6,797,163,000BOYAmt
EOY$8,128,780,000EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$294,440,350ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$498,992,000NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$221,506,650OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
HospitalYes (X)HospitalInd

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$34,535,000CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$169,497,434CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$31,560,247CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$42,290,773CurrentTaxYearMinus1YearAmt
Current Tax Year$257,200,000CurrentTaxYearAmt
Total$535,083,454TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$34,535,000CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$169,497,434CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$31,560,247CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$42,290,773CurrentTaxYearMinus1YearAmt
Current Tax Year$257,200,000CurrentTaxYearAmt
Total$535,083,454TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$150,754,520SubstantialContributorsTotAmt
Public Support Total170$384,328,934PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$47,403,556CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$90,780,000CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$70,401,294CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$34,044,000CurrentTaxYearMinus1YearAmt
Current Tax Year$10,141,000CurrentTaxYearAmt
Total$252,769,850TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt
FieldValueIRS element (for citing)
Total Support$787,853,304TotalSupportAmt
Gross Receipts Rltd Activities$3,073,395,227GrossReceiptsRltdActivitiesAmt
Public Support CY1700.48782PublicSupportCY170Pct
Public Support PY1700.43003PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3FormAndLineReferenceDesc
ExplanationTHE INTERNAL REVENUE SERVICE HAS DETERMINED THAT MEMORIAL SLOAN-KETTERING CANCER CENTER QUALIFIES AS A PUBLIC CHARITY UNDER SECTION 170 (B) (1) (A) (iii). HOWEVER, SINCE IT DOES NOT OPERATE A HOSPITAL, IT IS NOT REQUIRED TO COMPLETE SCHEDULE H.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Organization Belongs Afflt GrpYes (X)OrganizationBelongsAffltGrpInd
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$540,244FilingOrganizationsTotalAmt
Affiliated Group Total$935,326AffiliatedGroupTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$540,244FilingOrganizationsTotalAmt
Affiliated Group Total$935,326AffiliatedGroupTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,256,440,406FilingOrganizationsTotalAmt
Affiliated Group Total$6,143,421,674AffiliatedGroupTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,256,980,650FilingOrganizationsTotalAmt
Affiliated Group Total$6,144,357,000AffiliatedGroupTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt
Affiliated Group Total$1,000,000AffiliatedGroupTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt
Affiliated Group Total$250,000AffiliatedGroupTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$872,735CurrentYearMinus3Amt
Current Year Minus2$921,757CurrentYearMinus2Amt
Current Year Minus1$675,588CurrentYearMinus1Amt
Current Year$540,244CurrentYearAmt
Total$3,010,324TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART II-AFormAndLineReferenceDesc
ExplanationLOBBYING ACTIVITIES PERFORMED BY BOTH MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236) AND MEMORIAL HOSPITAL (EIN 13-1624082). LOBBYING EXPENDITURES ARE REPORTED ON THE STATEMENT OF FUNCTIONAL EXPENSE LINE 11d. THE CENTER HAS MADE THE 501(h) ELECTION. OUR AFFILIATED ORGANIZATIONS ARE IDENTIFIED BELOW. ALL AFFILIATES USE THE CORPORATE ADDRESS 1275 YORK AVENUE, NEW YORK, N.Y. 10065-6007. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (13-1624182), SKI REALTY, INC. (13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL (20-2212588), MSK. INSURANCE U.S., INC. (83-0363317), AND MSKCC PROTON INC., (35-2397819).ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$397,079,000BeginningYearBalanceAmt
Contributions$7,845,000ContributionsAmt
Investment Earnings Or Losses$934,000InvestmentEarningsOrLossesAmt
End Year Balance$405,858,000EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$396,451,000BeginningYearBalanceAmt
Contributions$636,000ContributionsAmt
Investment Earnings Or Losses-$8,000InvestmentEarningsOrLossesAmt
End Year Balance$397,079,000EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$385,622,000BeginningYearBalanceAmt
Contributions$10,435,000ContributionsAmt
Investment Earnings Or Losses$394,000InvestmentEarningsOrLossesAmt
End Year Balance$396,451,000EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$250,120,000BeginningYearBalanceAmt
Contributions$139,261,000ContributionsAmt
Investment Earnings Or Losses-$3,759,000InvestmentEarningsOrLossesAmt
End Year Balance$385,622,000EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$217,145,357BeginningYearBalanceAmt
Contributions$20,320,000ContributionsAmt
Investment Earnings Or Losses$12,654,643InvestmentEarningsOrLossesAmt
End Year Balance$250,120,000EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.45780BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.54220PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$341,952,000OtherCostOrOtherBasisAmt
Depreciation$107,743,000DepreciationAmt
Book Value$234,209,000BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$23,435,000OtherCostOrOtherBasisAmt
Depreciation$19,748,000DepreciationAmt
Book Value$3,687,000BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$866,362,000OtherCostOrOtherBasisAmt
Depreciation$627,675,000DepreciationAmt
Book Value$238,687,000BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$297,405,000OtherCostOrOtherBasisAmt
Depreciation$15,097,000DepreciationAmt
Book Value$282,308,000BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$758,891,000TotalBookValueLandBuildingsAmt
Financial DerivativesFinancialDerivativesGrp
Closely Held Equity InterestsCloselyHeldEquityInterestsGrp

Other Securities OtherSecuritiesGrp

FieldValueIRS element (for citing)
DescPRIVATE EQUITY & VENTURE CAPDesc
Book Value$1,967,776,000BookValueAmt
Method ValuationFMethodValuationCd
FieldValueIRS element (for citing)
Total Book Value Securities$1,967,776,000TotalBookValueSecuritiesAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (7 entries)

DescDescAmtAmt
PENSION AND POSTRETIREMENT$46,437,000
DEFERRED GIFT ANNUITY$16,442,000
ASSET RETIREMENT OBLIGATION$3,156,000
CAPTIVE INSURANCE LOAN AGREEME$71,799,000
ACCRUED SICK PAY$567,000
NET INTERCORPORATE LIABILITY$225,306,000
OTHER LIABILITIES$25,853,000
FieldValueIRS element (for citing)
Total Liability$389,560,000TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$2,022,997,000TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$498,992,000NetUnrealizedGainsInvstAmt
Revenue Not Reported$498,992,000RevenueNotReportedAmt
Revenue Subtotal$1,524,005,000RevenueSubtotalAmt
Investment Expenses Not Incld$27,416,000InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$27,416,000RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$1,551,421,000TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$1,229,564,650TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal$1,229,564,650ExpensesSubtotalAmt
Investment Expenses Not Incld2$27,416,000InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$27,416,000ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$1,256,980,650TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
INTENDED USE OF ENDOWMENT FUNDSPERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER.
FIN 48 LIABILITY FOR UNCERTAIN TAX POSITIONSA FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS.

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)05Program ServicesADMIN SUPPORT$1,072,673
Middle East and North Africa01Program ServicesADMIN SUPPORT$204,387
Central America and the Caribbean00Investments$3,148,653,396
Sub-Saharan Africa00Investments$63,436,653
Europe (Including Iceland and Greenland)00Investments$21,094,339
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees6SubtotalEmployeesCnt
Total Office0TotalOfficeCnt
Total Employee6TotalEmployeeCnt
Subtotal Spent$3,234,461,448SubtotalSpentAmt
Total Spent$3,234,461,448TotalSpentAmt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (true)PassiveForeignInvestmestCoInd
Foreign PartnershipYes (true)ForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE F, PART I , LINE 3, COLUMN fFormAndLineReferenceDesc
ExplanationVALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionYes (true)InitialContractExceptionInd
Rebuttable Presumption ProcYes (true)RebuttablePresumptionProcInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (21 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KATHRYN MARTIN
EVP & COO$1,427,165$0$287,106$0$46,218$0$39,200$0$46,372$0$1,846,061$0$16,500$0
CRAIG P THOMPSON MD
BOARD MBR, PRESIDENT & CEO$1,791,351$0$360,000$0$533,175$0$39,200$0$241,757$0$2,965,483$0$16,500$0
JASON KLEIN
SVP & CHIEF INVESTMENT OFFICER$976,596$0$594,840$0$1,159,822$0$39,200$0$47,825$0$2,818,283$0$16,500$0
MICHAEL HARRINGTON
evp & CFO$1,436,288$0$288,400$0$49,953$0$31,200$0$32,139$0$1,837,980$0$8,250$0
KERRY BESSEY
SVP & CHIEF HR OFFICER$703,818$0$510,773$0$46,388$0$39,200$0$42,157$0$1,342,336$0$16,500$0
JORGE LOPEZ ESQ
EVP & GENERAL COUNCEL$950,745$0$337,089$0$19,298$0$31,200$0$49,159$0$1,387,491$0$8,250$0
KENNETH MANOTTI
SVP DEVELOPMENT$892,932$0$315,620$0$42,085$0$31,200$0$36,041$0$1,317,878$0$8,250$0
EDWARD MAHONEY
SVP, FACILITIES MGMT & CONST$564,736$0$244,312$0$28,573$0$27,089$0$22,696$0$887,406$0$16,500$0
ERIC M COTTINGTON PHD
SVP, RESEARCH & TECH MGMT$636,930$0$261,209$0$51,999$0$38,364$0$35,605$0$1,024,107$0$32,500$0
PATRICIA C SKARULIS
FORMER SVP CIO until 12/2019$0$0$0$0$377,770$0$0$0$6,521$0$384,291$0$0$0
CLAUS JENSEN
EVP & CHIEF DIGITAL OFFICER$390,333$0$288,400$0$9,635$0$26,923$0$16,511$0$731,802$0$8,250$0
DEBRA BERNS ESQ
SVP & CHIEF RISK OFFICER$712,890$0$261,000$0$13,565$0$31,200$0$17,103$0$1,035,758$0$8,250$0
GREGORY RASKIN
VP, TECHNOLOGY DEVELOPMENT$580,704$0$491,750$0$69,695$0$31,200$0$43,287$0$1,216,636$0$8,250$0
MARK SVENNINGSON
SVP FINANCE$689,445$0$126,002$0$34,700$0$39,200$0$33,817$0$923,164$0$16,500$0
WENDY PERCHICK
SVP STRATEGIC PLANNING & INNOV$673,377$0$305,024$0$40,404$0$39,200$0$30,869$0$1,088,874$0$16,500$0
LARRY NORTON
SVP OFFICE OF THE PRESIDE/CEO$899,226$0$0$0$40,460$0$31,200$0$50,251$0$1,021,137$0$8,250$0
CAROLYN LEVINE ESQ
DEPUTY GEN COUNSEL CORP SECTY$439,477$0$89,116$0$12,775$0$30,980$0$28,006$0$600,354$0$7,880$0
AVICE MEEHAN
FORMER SVP CCO until 5/2019$0$0$0$0$198,979$0$0$0$11,714$0$210,693$0$0$0
PHILIP KANTOFF
VISITING INVESTIGATOR$731,532$0$0$0$753,246$0$31,200$0$16,555$0$1,532,533$0$8,250$0
ATEFEH RIAZI
CHIEF INFORMATION OFFICER$759,598$0$200,000$0$8,750$0$16,700$0$17,736$0$1,002,784$0$8,250$0
ROXANNE TAYLOR
CHIEF MARKET & COMM. OFFICER$750,009$0$375,000$0$24,633$0$31,200$0$6,974$0$1,187,816$0$8,250$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSUPPLEMENTAL COMPENSATION INFORMATIONFormAndLineReferenceDesc
ExplanationSCHEDULE J, PART I LINE 1A - BUSINESS OR FIRST-CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J, PART I LINE 4A - INCLUDED IN FORM 990 IS SEVERANCE PAY FOR AVICE MEEHAN, SVP & CHIEF COMMUNICATION OFFICER, OF $201,688, TERMINATED IN MAY 2019 AND PATRICIA SKARULIS, SVP & CHIEF INFORMATION OFFICER, OF $379,001, TERMINATED IN DECEMBER 2019. LINE 4B - JASON KLEIN WAS PAID $1,073,126 AS PART OF A DEFERRED COMPENSATION AGREEMENT. LINE 7 - INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. IN ADDITION, AS WELL AS AN OVERALL AUTHORIZATION AND APPROVAL FOR KEY EMPLOYEES AND OTHER MANAGEMENT INCLUDING PROFESSIONAL AND OTHER STAFF BY SETTING THE BONUS POOL IN CONJUNCTION WITH THE INPUT FROM HUMAN RESOURCES. STAFF BONUSES ARE IMPACTED BY ANNUAL MERIT REVIEW PROCESS. LINE 8 - AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT.ExplanationTxt

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (4 entries)

Bond ReferenceBondReferenceCdBond Issuer EINBondIssuerEINCUSIPCUSIPNumBond IssuedBondIssuedDtIssue PriceIssuePriceAmtPurposePurposeDescDefeasedDefeasedIndOn Behalf Of IssuerOnBehalfOfIssuerIndPool FinancingPoolFinancingInd
DORMITORY AUTHORITY OF THE STATE OF NEW YORK
A1460002936499063Z72013-06-28$80,000,000SEE PART VIfalsefalsefalse
DORMITORY AUTHORITY OF THE STATE OF NEW YORK
B1460002930000000002016-04-28$110,000,000SEE PART VIfalsefalsefalse
DORMITORY AUTHORITY OF THE STATE OF NEW YORK
C1460002930000000002016-09-09$145,000,000SEE PART VIfalsefalsefalse
NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY
D2220458170000000002017-12-20$335,567,386SEE PART VIfalsefalsefalse

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (4 entries)

Bond ReferenceBondReferenceCdRetiredRetiredAmtBond DefeasedBondDefeasedAmtTotal ProceedsTotalProceedsAmtIn Reserve FundInReserveFundAmtCapitalized InterestCapitalizedInterestAmtRefunding EscrowRefundingEscrowAmtIssuance Costs From ProceedsIssuanceCostsFromProceedsAmtCredit EnhancementCreditEnhancementAmtWorking Capital ExpendituresWorkingCapitalExpendituresAmtCapital ExpendituresCapitalExpendituresAmtOther Spent ProceedsOtherSpentProceedsAmtUnspentUnspentAmtSubstantial CompletionSubstantialCompletionYrRefunding Tax Exempt BondsRefundingTaxExemptBondsIndRefunding Taxable BondsRefundingTaxableBondsIndFinal Allocation MadeFinalAllocationMadeIndAdequate Books And Rec MaintAdequateBooksAndRecMaintInd
A$66,000,000$0$80,000,000$0$0$0$0$0$0$0$80,000,000$02013Yes (true)falseYes (true)Yes (true)
B$18,702,374$0$110,239,999$0$0$0$155,282$0$0$110,009,717$75,000$02017falsefalseYes (true)Yes (true)
C$76,125,000$0$145,000,000$0$0$0$72,861$0$0$144,627,139$300,000$02018falsefalseYes (true)Yes (true)
D$11,550,000$0$339,194,534$0$0$0$2,262,236$0$0$245,499,309$91,432,989$02019Yes (true)falseYes (true)Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (4 entries)

Bond ReferenceBondReferenceCdOwning Bond Financed PropertyOwningBondFinancedPropertyIndAny Lease ArrangementsAnyLeaseArrangementsIndMgmt Contract Bond Fincd PropMgmtContractBondFincdPropIndAny Research AgreementsAnyResearchAgreementsIndEngage Bond Counsel ResearchEngageBondCounselResearchIndPrivate Bus Use By OthersPrivateBusUseByOthersPctPrivate Bus Concerning UBIPrivateBusConcerningUBIPctTotal Private Business UseTotalPrivateBusinessUsePctBond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestIndChange In Use Bond Financed PropChangeInUseBondFinancedPropIndChange In Use Bond Financed PropChangeInUseBondFinancedPropPctRemedial Action TakenRemedialActionTakenIndProcs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
AfalsefalsefalseYes (true)false0.000000.000000.00000falsefalse0.00000falseYes (true)
BfalsefalsefalseYes (true)false0.000000.000000.00000falsefalse0.00000falseYes (true)
CfalsefalsefalseYes (true)false0.000000.000000.00000falsefalse0.00000falseYes (true)
DfalsefalsefalseYes (true)false0.000000.000000.00000false0.00000Yes (true)

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (4 entries)

Bond ReferenceBondReferenceCdForm8038 T FiledForm8038TFiledIndRebate Not Due YetRebateNotDueYetIndException To RebateExceptionToRebateIndNo Rebate DueNoRebateDueIndVariable Rate IssueVariableRateIssueIndHedge Identified In Bks And RecHedgeIdentifiedInBksAndRecIndGross Proceeds Invested In GICGrossProceedsInvestedInGICIndBusiness Name Line1GICProviderName/BusinessNameLine1TxtGross Proceeds InvestedGrossProceedsInvestedIndWritten Proc To Monitor ReqsWrittenProcToMonitorReqsInd
0
AfalsefalsefalseYes (true)falsefalsefalse0falseYes (true)
0
BfalsefalsefalseYes (true)falsefalsefalse0falseYes (true)
0
CfalsefalsefalseYes (true)falsefalsefalse0falseYes (true)
0
DfalseYes (true)falsefalsefalsefalsefalse0falseYes (true)

Procedures Corrective Action ProceduresCorrectiveActionGrp (4 entries)

Bond ReferenceBondReferenceCdProcedures Corrective ActionProceduresCorrectiveActionInd
AYes (true)
BYes (true)
CYes (true)
DYes (true)

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN (F) DESCRIPTION OF PURPOSEFormAndLineReferenceDesc
Explanation2013 SERIES BONDS (DASNY)- CUSIP #6499063Z7: 2013 SERIES BONDS WERE USED TO CURRENT REFUND THE 2010 SERIES BONDS ISSUED 9/2/2010. 2016 SERIES BONDS (DASNY) - CUSIP #000000000: 2016 SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. 2016 SERIES BONDS (NJEDA) - CUSIP #000000000: 2016 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. 2017 SERIES BONDS (DASNY)- CUSIP #000000000: 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS ISSUED JULY 16, 2015 AND CONSTRUCT VARIOUS FACILITIES. 2019 SERIES BONDS (DASNY) - CUSIP #64990GVG4: 2019 SERIES BONDS WERE USED TO REIMBURSE EXPENDITURES INCURRED TO CONSTRUCT A PATIENT CARE FACILITY. PART II LINE 3 - THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME AND GAINS/LOSSES. PART III LINE 3(D) - ANY MANAGEMENT CONTRACTS AND RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BONDS FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE OF AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. THE 2013 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON JUNE 21, 2019. THE DASNY 2016 SERIES BONDS REBATE CALCULATIONS WERE PERFORMED ON APRIL 14, 2021. THE NJEDA 2016 SERIES BONDS REBATE CALCULATIONS WERE PERFORMED ON JULY 6, 2022.ExplanationTxt

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd

Issuer Name IssuerName

FieldValueIRS element (for citing)
Business Name Line1DORMITORY AUTHORITY OF THE STATE OF NEW YORKBusinessNameLine1Txt
FieldValueIRS element (for citing)
Bond Issuer EIN146000293BondIssuerEIN
CUSIP64990GVG4CUSIPNum
Bond Issued2019-11-01BondIssuedDt
Issue Price$342,248,699IssuePriceAmt
PurposeSEE PART VIPurposeDesc
DefeasedfalseDefeasedInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Pool FinancingfalsePoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Retired$0RetiredAmt
Bond Defeased$0BondDefeasedAmt
Total Proceeds$342,248,699TotalProceedsAmt
In Reserve Fund$0InReserveFundAmt
Capitalized Interest$0CapitalizedInterestAmt
Refunding Escrow$0RefundingEscrowAmt
Issuance Costs From Proceeds$2,248,699IssuanceCostsFromProceedsAmt
Credit Enhancement$0CreditEnhancementAmt
Working Capital Expenditures$0WorkingCapitalExpendituresAmt
Capital Expenditures$340,000,000CapitalExpendituresAmt
Other Spent Proceeds$0OtherSpentProceedsAmt
Unspent$0UnspentAmt
Substantial Completion2019SubstantialCompletionYr
Refunding Tax Exempt BondsfalseRefundingTaxExemptBondsInd
Refunding Taxable BondsfalseRefundingTaxableBondsInd
Final Allocation MadeYes (true)FinalAllocationMadeInd
Adequate Books And Rec MaintYes (true)AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Owning Bond Financed PropertyfalseOwningBondFinancedPropertyInd
Any Lease ArrangementsfalseAnyLeaseArrangementsInd
Mgmt Contract Bond Fincd PropfalseMgmtContractBondFincdPropInd
Any Research AgreementsYes (true)AnyResearchAgreementsInd
Engage Bond Counsel ResearchfalseEngageBondCounselResearchInd
Private Bus Use By Others0.00000PrivateBusUseByOthersPct
Private Bus Concerning UBI0.00000PrivateBusConcerningUBIPct
Total Private Business Use0.00000TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt TestfalseBondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed PropfalseChangeInUseBondFinancedPropInd
Change In Use Bond Financed Prop0.00000ChangeInUseBondFinancedPropPct
Remedial Action TakenfalseRemedialActionTakenInd
Procs Nonqualified Bond RemdtdYes (true)ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Form8038 T FiledfalseForm8038TFiledInd
Rebate Not Due YetYes (true)RebateNotDueYetInd
Exception To RebatefalseExceptionToRebateInd
No Rebate DuefalseNoRebateDueInd
Variable Rate IssuefalseVariableRateIssueInd
Hedge Identified In Bks And RecfalseHedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

FieldValueIRS element (for citing)
Business Name Line10BusinessNameLine1Txt
FieldValueIRS element (for citing)
Gross Proceeds Invested In GICfalseGrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

FieldValueIRS element (for citing)
Business Name Line10BusinessNameLine1Txt
FieldValueIRS element (for citing)
Gross Proceeds InvestedfalseGrossProceedsInvestedInd
Written Proc To Monitor ReqsYes (true)WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Procedures Corrective ActionYes (true)ProceduresCorrectiveActionInd

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution248ContributionCnt
Noncash Contributions Rpt F990$3,324,493NoncashContributionsRptF990Amt
Method Of Determining RevenuesMARKET VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSALE OF NON CASH CONTRIBUTIONSFormAndLineReferenceDesc
ExplanationINCLUDED IN THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $1,597,665. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
NOTE A - AFFILIATED ORGANIZATIONSMEMORIAL SLOAN-KETTERING CANCER CENTER (THE CENTER) IS AFFILIATED WITH THE FOLLOWING 501 (C) (3) ORGANIZATIONS: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (THE INSTITUTE), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (THE HOSPITAL), S.K.I. REALTY, INC., MSK INSURANCE US, INC., THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, MSKCC PROPERTIES LLC, WITH THE HOSPITAL BEING THE SOLE MEMBER, THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM (PCCTC) AND MSKCC PROTON INC. WITH THE CENTER BEING THE SOLE MEMBER. THE ORGANIZATIONS SHARE CERTAIN FACILITIES AND VARIOUS SERVICES INCLUDING ADMINISTRATIVE, PLANT AND ANCILLARY SERVICES. THE FOLLOWING IS A SUMMARY OF SUCH SERVICES AMOUNTS IN 2021: SERVICES PROVIDED TO THE CENTER BY: THE HOSPITAL $ 16,964,000 THE INSTITUTION $ 9,660,000 S.K.I. REALTY, INC. $ 8,089,000 TOTAL $ 34,713,000 SERVICES PROVIDED BY THE CENTER TO: THE HOSPITAL $ 832,014,000 THE INSTITUTION $ 210,760,000 S.K.I. REALTY, INC. $ 5,223,000 GERSTNER GRADUATE SCHOOL $ 19,000 TOTAL $1,048,015,000 MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE COLLECTIVELY REFERRED TO AS "THE ORGANIZATION". THE CENTER CARRIES ON FUNDRAISING ACTIVITIES ON ITS OWN BEHALF AND ON BEHALF OF THE AFFILIATES. CONTRIBUTIONS AND PLEDGES ARE RECORDED BASED ON THE DONOR'S INTENT IN THE RECORDS OF THE APPROPRIATE ENTITY. FOR 2021, TOTAL CONTRIBUTIONS AND PLEDGES RAISED ON BEHALF OF THE CENTER, HOSPITAL, INSTITUTE AND GRADUATE SCHOOL WERE $576,500,000. CONTRIBUTORS' INFORMATION PROVIDED IN THE ATTACHED SCHEDULE B REPRESENTS THE DONORS' TOTAL PHILANTHROPIC CONTRIBUTIONS TO THE CENTER ONLY. IF ANY DONOR LISTED ON SCHEDULE B MADE CONTRIBUTIONS TO THE HOSPITAL, INSTITUTE, OR GRADUATE SCHOOL, THOSE CONTRIBUTIONS WOULD NOT BE REFLECTED ON THE ATTACHED SCHEDULE B. FUNDRAISING EXPENSES OF $71,894,554 WERE INCURRED AND REPORTED BY THE CENTER IN PART IX, STATEMENT OF FUNCTIONAL EXPENSES. THE CENTER IS ALSO INVOLVED IN LOBBYING FOR THE HOSPITAL AND INSTITUTE, SEE SCHEDULE C. PART II-A.
FORM 990, PART VI, LINE 2FOR THE TAX YEAR 2021, THE FOLLOWING BUSINESS RELATIONSHIPS WERE REPORTED: 1. DIRECTORS ELLEN V. FUTTER AND PETER J. SOLOMON 2. DIRECTORS ALEXANDER T. ROBERTSON AND CLIFTON S. ROBBINS 3. DIRECTORS ELLEN V. FUTTER AND RICHARD I. BEATTIE 4. DIRECTORS WILLIAM FORD AND HENRY FERNANDEZ FORM 990, PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SENIOR VICE PRESIDENT OF FINANCE AND THE CHIEF FINANCIAL OFFICER. IN ADDITION, FORM 990 IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. FORM 990, PART VI, LINE 12C IN 2021, MSK'S CONFLICT OF INTEREST (COI) PROGRAM WAS IMPLEMENTED THROUGH THREE COMPREHENSIVE POLICIES FOR MEMORIAL SLOAN KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES AND SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, WHICH ARE OUTLINED BELOW: 1. CONFLICT OF INTEREST AND COMMITMENT POLICY (THE "INDIVIDUAL COI POLICY"). a. THE INDIVIDUAL COI POLICY APPLIED TO: (I) PHYSICIANS AND SCIENTISTS WITH ACADEMIC APPOINTMENTS AT ANY LEVEL; (II) ANY CLINICAL PROVIDER WHO COULD INDEPENDENTLY WRITE ORDERS OR PRESCRIPTIONS; (III) INDIVIDUALS WHOSE ROLES INCLUDED THE DESIGN, CONDUCT OR REPORTING OF RESEARCH AND/OR WERE ENGAGED IN HUMAN SUBJECT RESEARCH; (IV) ADMINISTRATIVE EMPLOYEES WITH INDEPENDENT AUTHORITY TO MAKE PURCHASING DECISIONS OR WHO WERE OTHERWISE ABLE TO BIND, NEGOTIATE ON BEHALF, OR EXECUTE AGREEMENTS ON BEHALF OF, MSK; AND (V) INDIVIDUALS THAT SERVED ON MSK INSTITUTIONAL COMMITTEES WITH RESPONSIBILITY FOR OVERSIGHT OF RESEARCH, FORMULARY, OR PURCHASING DECISIONS. b. MSK'S COMPLIANCE COI OFFICE ("COMPLIANCE") AND THE INSTITUTIONAL CONFLICT OF INTEREST COMMITTEE (THE "MSK COI COMMITTEE") WERE RESPONSIBLE FOR THE ADMINISTRATION OF THIS POLICY, UNDER THE OVERSIGHT OF THE NEWLY CREATED COMMITTEE OF THE BOARD (THE "BOARD COI COMMITTEE") DEDICATED EXCLUSIVELY TO DISCHARGING THE BOARD'S RESPONSIBILITY AND AUTHORITY OVER MSK'S CONFLICTS OF INTEREST PROGRAM. c. UPON BECOMING COVERED BY THE INDIVIDUAL COI POLICY, ANNUALLY THEREAFTER AND/OR AS NEW SIGNIFICANT INTERESTS AROSE, AN INDIVIDUAL WAS REQUIRED TO DISCLOSE FINANCIAL INTERESTS AND EXTERNAL RELATIONSHIPS AND ACTIVITIES ("INTERESTS"), WHETHER PAID OR UNPAID, THAT REASONABLY APPEARED TO BE RELATED TO THE INDIVIDUAL'S INSTITUTIONAL RESPONSIBILITIES. COVERED PERSONS WERE REQUIRED TO DISCLOSE INTERESTS FOR THEMSELVES AND IMMEDIATE FAMILY MEMBERS. d. DEPENDING ON THE CIRCUMSTANCES AND BASED ON ESTABLISHED CRITERIA, DISCLOSED INTERESTS WERE REVIEWED BY COMPLIANCE, THE MSK COI COMMITTEE, MSK COI COMMITTEE DESIGNEE(S), AND/OR THE BOARD COI COMMITTEE TO DETERMINE WHETHER AN INDIVIDUAL CONFLICT OF INTEREST EXISTED OR PRESENTED THE PERCEPTION THEREOF (I.E. WHETHER AN INDIVIDUAL FINANCIAL INTEREST COULD DIRECTLY AND SIGNIFICANTLY IMPACT AN INDIVIDUAL'S INSTITUTIONAL RESPONSIBILITIES, OR AN INDIVIDUAL'S INTEREST COULD BE DIRECTLY AND SIGNIFICANTLY IMPACTED BY THEIR INSTITUTIONAL RESPONSIBILITIES). e. THE POLICY REQUIRED ANY INDIVIDUAL CONFLICT OF INTEREST TO BE MANAGED, REDUCED OR ELIMINATED. WHEN A CONFLICT OF INTEREST DETERMINATION WAS MADE, THE MSK COI COMMITTEE, THE MSK COI COMMITTEE DESIGNEE(S), OR THE BOARD COI COMMITTEE, AS APPLICABLE, DETERMINED HOW TO ADDRESS IT. FOR THOSE CONFLICTS DEEMED MANAGEABLE, MANAGEMENT STRATEGIES IMPLEMENTED INCLUDED DISCLOSURE OF THE INTEREST IN RELEVANT PUBLICATIONS, PRESENTATIONS, CONSENT FORMS, AND EDUCATIONAL MATERIALS; RECUSAL AND/OR OTHER LIMITATION ON ROLE; INDEPENDENT OVERSIGHT BY A DISINTERESTED SENIOR PERSONNEL MEMBER OR COMMITTEE; AND TEMPORARY OR PERMANENT REDUCTION, DIVESTITURE, RELINQUISHMENT, OR TERMINATION OF AN INDIVIDUAL'S INTEREST. 2. INSTITUTIONAL CONFLICT OF INTEREST POLICY (THE "INSTITUTIONAL COI POLICY"). a. THE INSTITUTIONAL COI POLICY APPLIED TO FINANCIAL INTERESTS AND RELATIONSHIPS ("INTERESTS") HELD BY MSK AS AN INSTITUTION, AS WELL AS THOSE FINANCIAL INTERESTS AND RELATIONSHIPS ("INTERESTS") HELD BY FIVE SENIOR EXECUTIVE OFFICERS DEEMED "INSTITUTIONAL OFFICIALS,THEIR IMMEDIATE FAMILY MEMBERS. INSTITUTIONAL OFFICIALS INCLUDED THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE PHYSICIAN-IN-CHIEF AND CHIEF MEDICAL OFFICER, THE CHIEF OPERATING OFFICER, THE CHIEF FINANCIAL OFFICER, AND THE DIRECTOR OF THE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. b. INSTITUTIONAL INTERESTS HELD BY MSK WERE MADE AVAILABLE TO COMPLIANCE THROUGH REGULAR REPORTS FROM AND ONGOING ENGAGEMENT WITH RELEVANT MSK DEPARTMENTS. INSTITUTIONAL INTERESTS HELD BY INSTITUTIONAL OFFICIALS WERE DISCLOSED THROUGH THE PROCESS DESCRIBED ABOVE IN THE INDIVIDUAL COI POLICY, AS WELL AS THE PROCESS DESCRIBED BELOW IN THE BOARD COI POLICY. c. THE MSK COI COMMITTEE OR MSK COI COMMITTEE DESIGNEE(S) WERE RESPONSIBLE FOR DETERMINING WHETHER AN INSTITUTIONAL CONFLICT OF INTEREST EXISTED, I.E. WHETHER THE INSTITUTIONAL INTEREST HELD BY MSK OR AN INSTITUTIONAL OFFICIAL (OR THEIR IMMEDIATE FAMILY MEMBERS) COULD, OR COULD REASONABLY BE PERCEIVED TO, DIRECTLY AND SIGNIFICANTLY AFFECT THE DESIGN, CONDUCT, REPORTING, REVIEW, OR OVERSIGHT OF MSK RESEARCH OR THE OUTCOME OF AN MSK ACTIVITY OR DECISION. d. THE POLICY REQUIRED ANY INSTITUTIONAL CONFLICT OF INTEREST TO BE MANAGED, REDUCED OR ELIMINATED. WHEN AN INSTITUTIONAL CONFLICT OF INTEREST DETERMINATION WAS MADE, THE MSK COI COMMITTEE AND/OR THE MSK COI COMMITTEE DESIGNEE(S) DETERMINED HOW TO ADDRESS IT. FOR THOSE CONFLICTS DEEMED MANAGEABLE, MANAGEMENT STRATEGIES IMPLEMENTED INCLUDED RECUSAL OF THE APPLICABLE INSTITUTIONAL OFFICIAL FROM DECISION-MAKING REGARDING THE ARRANGEMENT AND DISCLOSURE TO RELEVANT PERSONNEL; DISCLOSURE OF THE INTEREST IN RELEVANT PUBLICATIONS, PRESENTATIONS, CONSENT FORMS, AND EDUCATIONAL MATERIALS; INDEPENDENT OVERSIGHT BY A DISINTERESTED SENIOR PERSONNEL MEMBER OR COMMITTEE; AND TEMPORARY OR PERMANENT REDUCTION, DIVESTITURE, RELINQUISHMENT, OR TERMINATION OF MSK'S OR AN INSTITUTIONAL OFFICIAL'S INSTITUTIONAL INTEREST. 3. BOARDS OF GOVERNING TRUSTEES CONFLICT OF INTEREST POLICY (THE "BOARD COI POLICY"). a. THE BOARD COI POLICY APPLIED TO BOARD MEMBERS, OFFICERS, AND OTHER MSK SENIOR LEADERSHIP. INDIVIDUALS COVERED BY THE BOARD COI POLICY WERE REQUIRED TO DISCLOSE FINANCIAL INTERESTS AND RELATIONSHIPS, AS DEFINED BY THE POLICY, ANNUALLY AND ON AN ONGOING BASIS. OTHER ENTITIES IN THE SAME TAX-EXEMPT GROUP HAD OVERLAPPING OFFICERS AND BOARD MEMBERS AS DESCRIBED IN SCHEDULE O; SUCH PERSONS REPORTED FINANCIAL INTERESTS THROUGH THIS OR RELATED PROCESSES. b. THE BOARD COI COMMITTEE WAS RESPONSIBLE FOR DETERMINING WHETHER ANY INTEREST DISCLOSED UNDER THE BOARD COI POLICY GAVE RISE TO A CONFLICT OF INTEREST. THE POLICY REQUIRED THAT THE MEMBERS OF THE BOARD COI COMMITTEE VOTE, WITHOUT THE INDIVIDUAL WITH THE POTENTIAL CONFLICT PRESENT, TO DETERMINE WHETHER A CONFLICT OF INTEREST EXISTED. ALL MEMBERS PARTICIPATING IN THE VOTE WERE REQUIRED TO BE DISINTERESTED WITH RESPECT TO THE TRANSACTION, ARRANGEMENT, OR RELATIONSHIP. c. THE COVERED INDIVIDUAL WITH THE CONFLICT OF INTEREST COULD MAKE A PRESENTATION TO THE BOARD COI COMMITTEE, BUT COULD NOT PARTICIPATE IN OR INFLUENCE THE DISCUSSION OF, OR VOTE ON, THE PROPOSED TRANSACTION, ARRANGEMENT, OR RELATIONSHIP. THE EXISTENCE AND RESOLUTION OF ANY CONFLICT OF INTEREST, ALONG WITH ASSOCIATED DETERMINATIONS MADE AND VOTES TAKEN, WERE REQUIRED TO BE DOCUMENTED IN WRITING. d. FOR ANY TRANSACTION, ARRANGEMENT, OR RELATIONSHIP THAT INVOLVED A CONFLICT OF INTEREST, A CONFLICT MANAGEMENT PLAN COULD BE IMPLEMENTED IF DOING SO WAS IN THE BEST INTERESTS OF MSK. MANAGEMENT PLANS COULD REQUIRE DISCLOSURE, RECUSAL OR OTHER LIMITATION OF ROLE, INDEPENDENT OVERSIGHT AND CONFIDENTIALITY.
FORM 990, PART VI, LINE 15MEMORIAL SLOAN-KETTERING CANCER CENTER IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE BOARD OF TRUSTEES AND GOVERNING TRUSTEES HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARD TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC'S, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS MARCH 2021, WHICH SET THE COMPENSATION FOR THE PERIOD APRIL 2021 TO MARCH 2022. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS' GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX-EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS.
FORM 990, PART VI, LINE 19THE AUDITED FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE ORGANIZATION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND THE APPLICABLE 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST AND IT ALSO CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT AVAILABLE TO THE PUBLIC. FORM 990, PART VII, SECTION B AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS FOR SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. FORM 990, PART XI, LINE 9 CHANGE IN POSTRETIREMENT REVENUE $231,707,800 OTHER NON-OPERATING EXPENSES ($10,201,150) TOTAL-OTHER CHANGES IN NET ASSETS $221,506,650 FORM 990, PART XII, LINE 2 THE FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AUDITED BY AN INDEPENDENT ACCOUNTING FIRM ON A COMBINED BASIS. THE COMBINED STATEMENTS INCLUDE THE ACCOUNTS OF THE FOLLOWING TAX EXEMPT, SECTION 501 (C) (3), INCORPORATED AFFILIATES: MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (EIN 13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (EIN 13-1624182), S.K.I. REALTY, INC. (EIN 13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (EIN 20-2212588), AND MSK INSURANCE US, INC.(MVI) EIN 83-0363317. INCLUDED IN THE GROUP EXEMPTION IS MSKCC PROPERTIES LLC (EIN 35-2464610) WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER, AND MSKCC PROTON, INC. (EIN 35-2397819). THE CENTER'S FINANCIAL STATEMENTS ARE NOT AUDITED INDEPENDENT OF THE COMBINED. REFER TO SCHEDULE D FOR A RECONCILIATION OF THE 990 TO THE CENTER'S FINANCIAL STATEMENTS.
STRATEGIC PLANNING AND COMMUNITY BENEFITSMEMORIAL SLOAN-KETTERING CANCER CENTER (MSK) AND ITS AFFILIATES AS REPORTED ON A COMBINED BASIS WITH A SEPARATE GROUP 990 FILING UNDER EIN # 91-2154236. MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE INTERTWINED WITH A FINANCIAL ASSISTANCE PROGRAM AND COMMUNITY BENEFIT ACTIVITIES AS OUTLINED BELOW. MSK'S INPATIENT HOSPITAL IS IN MID-MANHATTAN WITH ADDITIONAL OUTPATIENT TREATMENT CENTERS IN BROOKLYN, LONG ISLAND, WESTCHESTER COUNTY, AND NEW JERSEY. OUR PRIMARY CATCHMENT AREA ENCOMPASSES 23 COUNTIES ACROSS THE FIVE BOROUGHS OF NEW YORK CITY, LONG ISLAND, SOUTHERN NEW YORK STATE, NEW JERSEY, AND SOUTHWESTERN CONNECTICUT. A TOTAL OF 201,586 PATIENTS WERE SEEN AT MSK'S FACILITIES IN 2021, INCLUDING 184,175 PATIENTS FROM THE TRI-STATE AREA (NY, NJ, CT); 16,994 PATIENTS FROM OTHER PARTS OF THE UNITED STATES; AND 417 PATIENTS FROM OTHER COUNTRIES. THESE PATIENTS ACCOUNTED FOR 24,142 ADMISSIONS TO OUR HOSPITAL WITH 160,922 RELATED PATIENT DAYS AND 904,743 OUTPATIENT VISITS AT OUR COMBINED FACILITIES IN NEW YORK CITY AND THE REGION. SINCE 1987, MSK HAS HAD A FINANCIAL ASSISTANCE PROGRAM (FAP) IN PLACE TO ASSIST UNDERINSURED AND UNINSURED PATIENTS WHO ARE EXPERIENCING DIFFICULTIES MEETING THEIR FINANCIAL RESPONSIBILITIES TO MEMORIAL HOSPITAL AND ITS PHYSICIANS. FINANCIAL COUNSELORS WORK WITH PATIENTS AND INSURANCE COMPANIES INCLUDING MEDICARE AND MEDICAID TO HELP THEM ACCESS SERVICES. THOSE WHO DO NOT QUALIFY FOR PUBLICLY AVAILABLE HEALTH INSURANCE, OR WHO ARE UNABLE TO PAY THEIR PORTION OF FEES ABOVE INSURANCE REIMBURSEMENT, MAY OBTAIN HELP THROUGH THE INSTITUTION'S FAP IF THEY ARE ELIGIBLE. THE INSTITUTION USES A 500% OF THE FEDERAL POVERTY LEVEL (FPL) AS AN ANNUAL INCOME GUIDELINE, TO DETERMINE A PATIENT'S ELIGIBILITY. HOWEVER, A PATIENT MAY QUALIFY FOR FAP EVEN WITH AN INCOME EXCEEDING THE 500% FPL. THAT'S BECAUSE WE ALLOW A DEDUCTION FOR MONTHLY ROUTINE HOUSEHOLD BILLS BASED ON FAMILY SIZE. PATIENTS WITH A ZERO OR NEGATIVE BALANCE ARE THEREFORE, ELIGIBLE FOR THE PROGRAM UNLESS THEY HAVE LARGE ASSETS NOT LINKED TO THEIR RETIREMENT OR EDUCATION. MORE INFORMATION ON THE FINANCIAL ASSISTANCE PROGRAM CAN BE OBTAINED ON THE MSK'S WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE. THE TABLE BELOW ALSO ILLUSTRATES THE INCOME GUIDELINE USED IN EVALUATING THE PATIENT'S FINANCIAL STATUS. FAMILY SIZE ALLOWED INCOME RESOURCE LEVELS 1 $ 64,400 $ 37,875 2 $ 87,100 $ 55,500 3 $109,800 $ 62,535 4 $132,500 $ 70,688 5 $155,200 $ 78,848 6 $177,900 $ 87,000
STRATEGIC PLANNING AND COMMUNITY BENEFITS - CONTINUEDMSKCC'S STRATEGIC PLANNING PROCESS INCLUDES DEVELOPING PROGRAMS IN RESPONSE TO CANCER MORBIDITY AND MORTALITY DATA, DEMOGRAPHIC DATA, AND COMMUNITY INPUT IN ACCORDANCE WITH THE IRS COMMUNITY HEALTH NEEDS ASSESSMENTS REQUIREMENTS. THESE FINDINGS ARE USED IN DESIGNING THE IMPLEMENTATION STRATEGY TO PLAN INITIATIVES AND PROGRAMS AIMED AT IMPROVING OUR COMMUNITIES' ACCESS TO CANCER INFORMATION, CANCER CARE. THE ORGANIZATION'S STRATEGIC EFFORTS ARE ALSO FOCUSED ON REDUCING THE CRITICAL ISSUE OF CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. THESE PROGRAM SERVICES ARE OFFERED THROUGH VARIOUS CHANNELS WITHIN THE INSTITUTION. THE MSK RALPH LAUREN CENTER (RLC), PROVIDES CANCER PREVENTION, SCREENING, DIAGNOSIS, AND TREATMENT AS WELL AS SOCIAL SERVICES, FINANCIAL COUNSELING AND A FOOD PANTRY SUPPLEMENTED WITH NUTRITIONAL COUNSELING. RLC'S SCOPE OF SERVICES INCLUDE BREAST CANCER EVALUATION, DIAGNOSTIC AND TREATMENT SERVICES, INCLUDING CHEMOTHERAPY, FOR MOST CANCERS AND BLOOD DISEASES, AND SCREENING SERVICES FOR BREAST, CERVICAL, COLON, PROSTATE AND LUNG CANCER AND SMOKING CESSATION PROGRAM. RLC IS STAFFED BY MEDICAL ONCOLOGISTS, A BREAST SURGEON, APP'S, REGISTERED NURSES, PATIENT CARE TECHNICIANS, A DIETICIAN/NUTRITIONIST, RADIOLOGY TECHNOLOGISTS, AND LAB TECHNICIANS. REFERRALS TO CLINICIANS, PROGRAMS, AND FACILITIES WITHIN MEMORIAL HOSPITAL ARE COORDINATED FOR PATIENTS REQUIRING SUCH SERVICES. TO-DATE RLC HAS MANAGED MORE THAN 180,000 PATIENT VISITS AND REPORTED MORE THAN 2,000 FINANCIAL ASSESSMENT CASES. THE PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT'S PSYCHIATRISTS AND PSYCHOLOGISTS USE THEIR EXPERTISE TO ASSIST PATIENTS WITH THE SPECTRUM OF PSYCHIATRIC AND BEHAVIORAL ISSUES THAT ARISE DURING DIAGNOSIS AND TREATMENT. THE DEPARTMENT ALSO WORKS TO DEEPEN ITS UNDERSTANDING AND EXPAND TREATMENT OPTIONS FOR ONCOLOGY PATIENTS AROUND THE GLOBE THROUGH CLINICAL TRIALS, RESEARCH, AND OTHER MEANS. THE DEPARTMENT ALSO OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. SERVICES PROVIDED INCLUDE CONSULTATIONS AND EVALUATION, PSYCHOTHERAPY, MEDICATION MANAGEMENT AND PHARMACOTHERAPY, SUPPORTIVE COUNSELING, SMOKING CESSATION, HYPNOTHERAPY, AND VARIOUS DIAGNOSTIC TESTS, AND OTHERS. DURING 2021, THE DEPARTMENT EXPERIENCED 32,600 INPATIENT AND OUTPATIENT ENCOUNTERS WITH 1,739 PATIENTS TREATED THROUGH THE SMOKING CESSATION PROGRAM. APPROXIMATELY $4.49M WAS EXPENDED BY THE DEPARTMENT TO SUPPORT ITS COMMUNITY BENEFIT-RELATED PROGRAMS. AT MSK WE BELIEVE IN CARING FOR THE WHOLE PERSON NOT JUST THE DISEASE OR SYMPTOM. INTEGRATIVE MEDICINE WEAVES NATURAL TREATMENTS SUCH AS ACUPUNCTURE, MASSAGE, AND YOGA INTO OUR OVERALL CARE PLAN. ALL OF OUR HOLISTIC HEALTH SERVICES AND PROGRAMS ARE BASED ON THE LATEST SCIENTIFIC EVIDENCE. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS. DURING 2021, THE DEPARTMENT SERVICED 7,903 PATIENT VISITS. THESE CLINICAL SERVICES INCLUDED MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA AND YOGIC BREATHING, MEDITATION AND GUIDED IMAGERY, KARATE AND DANCE THERAPY. WE ALSO PROVIDED EXTENSIVE EDUCATION FOR PATIENTS AND CAREGIVERS DURING BEDSIDE AND GROUP VISITS. IN ADDITION, WE OFFER OUTPATIENT ACUPUNCTURE CONSULTATIONS TO ANYONE IN THE COMMUNITY AT NO COST TO THEM. THESE CONSULTATIONS ADVISED CLIENTS ON HOW ACUPUNCTURE COULD BENEFIT THEIR CONDITION BASED ON THEIR SPECIFIC THERAPEUTIC NEEDS. THERE WERE 91 ACUPUNCTURE CONSULTATIONS PROVIDED IN 2021. THE DEPARTMENT INCURRED $1.53M IN PERSONNEL COST TO DELIVER COMMUNITY BENEFIT-RELATED PROGRAMS. MSK ENGAGES IN AND SUPPORTS COALITION-BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES IT SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR VARIOUS TYPES OF CANCER. FOR INSTANCE, MSK SPONSORS SEVERAL PROGRAMS THAT GIVE MEDICAL STUDENTS, UNDERGRADUATES, AND HIGH SCHOOL STUDENTS THE OPPORTUNITY TO WORK AT THE INSTITUTION DOING CLINICAL AND LABORATORY RESEARCH. THROUGH THESE PROGRAMS, MEMORIAL SLOAN KETTERING STRIVES TO INCREASE THE PIPELINE OF SCIENTISTS AND PHYSICIANS WORKING IN ONCOLOGY. IN 2021, THE ORGANIZATION ESTABLISHED THE OFFICE OF HEALTH EQUITY (OHE) TO ADDRESS CANCER DISPARITIES THAT EXIST DUE TO RACIAL, ETHNIC, CULTURAL, OR SOCIOECONOMIC BARRIERS. THROUGH A PATIENT CENTRIC FOCUS, THE OHE IS RESPONSIBLE FOR LEADING PATIENT CARE AND RESEARCH ACTIVITIES INCLUDING THE CANCER HEALTH EQUITY RESEARCH PROGRAM (CHERP) AND CANCER EQUITY PROGRAMS. INTEGRAL TO OHE'S ROLE IS THE DEVELOPMENT OF HEALTH EQUITY RESEARCH AND EDUCATION AND TRAINING. AS SUCH THE OHE HAS IMPLEMENTED RECRUITING AND TRAINING INITIATIVES ACROSS THE INSTITUTION. THE OBJECTIVE OF THESE TRAINING PROGRAMS IS TO ENHANCE THE DIVERSITY OF FUTURE CANCER RESEARCH WORKFORCE BY PROVIDING MINORITY STUDENTS WITH EXPOSURE TO CUTTING-EDGE CANCER RESEARCH WITH RENOWNED MENTORS. OUR BASIC AND TRANSLATIONAL RESEARCHERS HAVE MADE MANY SIGNIFICANT CONTRIBUTIONS TO THE SCIENTIFIC COMMUNITY'S UNDERSTANDING OF CANCER BIOLOGY AND CANCER GENETICS AS WELL AS TO RELATED FIELDS CELL BIOLOGY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, DEVELOPMENTAL BIOLOGY, MOLECULAR PHARMACOLOGY AND CHEMISTRY, IMMUNOLOGY, COMPUTATIONAL BIOLOGY, AND DRUG DEVELOPMENT. GENES FIRST IDENTIFIED IN OUR LABORATORIES ARE NOW THE FOCUS OF INTENSE RESEARCH IN OTHER LABORATORIES AROUND THE WORLD. DRUGS, MONOCLONAL ANTIBODIES, AND OTHER AGENTS FIRST DEVELOPED IN OUR LABORATORIES HAVE GONE ON TO GAIN REGULATORY APPROVAL FOR TREATING PATIENTS WORLDWIDE. RECENT EXPANSION OF OUR LABORATORY SPACE HAS ALLOWED US TO GROW OUR RESEARCH EFFORTS SO THAT GOING FORWARD WE CAN CONTINUE TO MAKE DISCOVERIES THAT WILL CHANGE THE WAY THE WORLD UNDERSTANDS CANCER AND AID IN THE DEVELOPMENT OF BETTER TREATMENTS FOR CANCER PATIENTS EVERYWHERE. IN 2021, MEMORIAL SLOAN KETTERING SPENT $662.3M IN SUPPORT OF ITS RESEARCH MISSION, OF WHICH $241.0M WAS SPONSORED BY GOVERNMENTAL AND OTHER NON-PROFIT ORGANIZATIONS, $142.4M FROM PHILANTHROPY, AND $278.9M FROM THE INSTITUTION'S FUNDS. EDUCATION AND TRAINING ARE KEY COMPONENTS OF MEMORIAL SLOAN KETTERING'S MISSION AND IMPORTANT EXAMPLES OF HOW THE INSTITUTION MAKES CONTRIBUTIONS TO THE CARE AND TREATMENT OF CANCER PATIENTS FAR BEYOND ITS OWN WALLS THROUGH WORKFORCE DEVELOPMENT. OUR TRAINING, GRADUATE, AND CONTINUING EDUCATION PROGRAMS PREPARE PHYSICIANS, SCIENTISTS, NURSES, AND TECHNICIANS TO BE LEADERS IN THEIR CHOSEN FIELDS. THESE HEALTHCARE PROVIDERS CAN THEN TAKE THE EXPERTISE GAINED FROM WORKING WITH OUR SPECIALISTS TO OTHER HEALTHCARE INSTITUTIONS AROUND THE COUNTRY AND THROUGHOUT THE WORLD. MSK ALSO TRAINS GRADUATE STUDENTS AND POSTDOCTORAL RESEARCHERS WORKING IN MANY AREAS OF BASIC SCIENCE AND TRANSLATIONAL RESEARCH. WHEN THESE YOUNG SCIENTISTS COMPLETE THEIR TRAINING, THEY BRING THE SKILLS OBTAINED IN OUR LABORATORIES INTO THE ACADEMIC COMMUNITY AT LARGE AS WELL AS THE PRIVATE SECTOR. MEMORIAL SLOAN KETTERING UTILIZED $213.9M OF THE INSTITUTION'S RESOURCES DURING 2021 TO SUPPORT ITS EDUCATION AND TRAINING MISSION, WHICH WE CONSIDER VITAL, GIVEN OUR LEADERSHIP ROLE IN CANCER CARE TREATMENT AND RESEARCH. $58.0M OF THE AMOUNT WAS SPONSORED BY GOVERNMENTAL AND OTHER REVENUE SOURCES AND $155.9M FROM THE INSTITUTION'S GENERAL FUND. COVID-19 ON MARCH 11, 2020, THE WORLD HEALTH ORGANIZATION DESIGNATED THE COVID-19 OUTBREAK AS A GLOBAL PANDEMIC. FEDERAL, STATE AND LOCAL GOVERNMENT POLICIES RESULTED IN A SUBSTANTIAL PORTION OF THE POPULATION REMAINING AT HOME AND FORCED THE CLOSURE OF CERTAIN BUSINESSES. THESE ACTIONS PRESENTED UNPRECEDENTED CHALLENGES TO ALL, INCLUDING THE MEDICAL COMMUNITY AS THEY GRAPPLED TO CONTAIN THE DEADLY COVID-19 PANDEMIC WHILE CARING FOR THE RAPID SURGE OF ITS AILING CONSTITUENTS. THE INSTITUTION RESPONDED QUICKLY TO LEAD OUR COMMUNITIES THROUGH A SERIES OF VIRTUAL INFORMATION SESSIONS TO EDUCATE THE COMMUNITY ABOUT THE COVID-19 VIRUS, CONTINUING CARE, AND OTHER CANCER-RELATED TOPICS. MSK ALSO DEVELOPED THE FIRST COVID-19 TEST IN NEW YORK CITY. THIS GAME-CHANGING ACHIEVEMENT CREATED ROBUST TESTING CAPACITY SINCE THE EARLY DAYS OF THE PANDEMIC. MSK'S CONTRIBUTION TO THE FIGHT AGAINST COVID EXTENDED FAR BEYOND OUR INSTITUTION. OUR FACULTY HAVE GENERATED MORE THAN 230 COVID-19 RELATED PUBLICATIONS RANGING FROM PRACTICE-CHANGING GUIDELINES TO THE FIRST REPORTS OF THE CLINICAL EXPERIENCE IN TREATING CANCER PATIENTS WITH COVID-19, TO PROMISING COVID-19 DRUGS CANDIDATES AND NEW INSIGHTS INTO THE STRUCTURE AND FUNCTION OF THE VIRUS. IN ADDITION, THE INSTITUTION GREATLY EXPANDED ITS FOOD PANTRY AND INCREASED THE AMOUNT OF FOOD DISTRIBUTED. WITH THE HELP OF THE TRANSPORTATION TEAM, FOOD WERE DELIVERED TO BOTH THE PATIENTS AND THEIR FAMIL

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1PROSTATE CANCER CLINICAL TRIALSBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11275 YORK AVEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10065ZIPCd
FieldValueIRS element (for citing)
EIN352506225EIN
Primary ActivitiesCANCER CAREPrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd
Total Income$13,123,000TotalIncomeAmt
End Of Year Assets$7,097,000EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1MSKCCBusinessNameLine1Txt

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1MEMORIAL MEDICAL CARE PCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11275 YORK AVENUEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10065ZIPCd
FieldValueIRS element (for citing)
EIN352491455EIN
Primary ActivitiesCANCER CAREPrimaryActivitiesTxt
Legal Domicile StateNYLegalDomicileStateCd
Exempt Code Section501 (C )3ExemptCodeSectionTxt
Public Charity Status10PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1MSKCCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Controlled OrganizationYes (true)ControlledOrganizationInd

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp (34 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtPredominant Income TypePredominantIncomeTypeTxtShare Of Total IncomeShareOfTotalIncomeAmtShare Of EOY AssetsShareOfEOYAssetsAmtDisproportionate AllocationsDisproportionateAllocationsIndUBI Code VUBICodeVAmtGeneral Or Managing PartnerGeneralOrManagingPartnerIndOwnershipOwnershipPct
MEM RADIATION ONCOL
1275 YORK AVENYNY10065133237927HEALTH CARENYMEMRELATED$25,879,360$0false$0Yes (true)0.01000
MEM PATHOLOGY GROUP
1275 YORK AVENYNY10065133365998HEALTH CARENYMEMRELATED$54,980,013$0false$0Yes (true)0.01000
MEM ANESTHESIOLOGY
1275 YORK AVENYNY10065133367135HEALTH CARENYMEMRELATED$63,040,942$0false$0Yes (true)0.01000
MEM PEDIATRICS GRP
1275 YORK AVENYNY10065133346908HEALTH CARENYMEMRELATED$9,618,517$0false$0Yes (true)0.01000
MEM NEUROLOGY GROUP
1275 YORK AVENYNY10065133399377HEALTH CARENYMEMRELATED$14,368,486$0false$0Yes (true)0.01000
MEM PSYCHIATRY GRP
1275 YORK AVENYNY10065133430629HEALTH CARENYMEMRELATED$6,605,121$0false$0Yes (true)0.01000
MSK NASSAU
1275 YORK AVENYNY10065611904151HEALTH CARENYMEMRELATED$13,144,981$0false$0Yes (true)0.01000
MEM INFECT DISEASE
1275 YORK AVENYNY10065133278582HEALTH CARENYMEMRELATED$2,792,172$0false$0Yes (true)0.01000
MSK SURGERY GROUP
1275 YORK AVENYNY10065134010372HEALTH CARENYMEMRELATED$172,773,407$0false$0Yes (true)0.01000
MSK HAUPPAUGE
1275 YORK AVENYNY10065134059247HEALTH CARENYMEMRELATED$5,832,290$0false$0Yes (true)0.01000
INTERGRATIVE MED
1275 YORK AVENYNY10065542092060HEALTH CARENYMEMRELATED$2,068,058$0false$0Yes (true)0.01000
MSK-REGIONAL NETWK
1275 YORK AVENYNY10065020594889HEALTH CARENYMEMRELATED$17,220,511$0false$0Yes (true)0.01000
MSK BASKING RIDGE
1275 YORK AVENYNY10065593801080HEALTH CARENYMEMRELATED$15,429,072$0false$0Yes (true)0.01000
MEM URGENT CARE GRP
1275 YORK AVENYNY10065651263291HEALTH CARENYMEMRELATED$6,827,987$0false$0Yes (true)0.01000
MEM CLN GENETICS
1275 YORK AVENYNY10065651263292HEALTH CARENYMEMRELATED$955,233$0false$0Yes (true)0.01000
MEM DEVELOP CHEMO
1275 YORK AVENYNY10065133278548HEALTH CARENYMEMRELATED$5,833,381$0false$0Yes (true)0.01000
MEM MEDICAL CONSULT
1275 YORK AVENYNY10065133278550HEALTH CARENYMEMRELATED$10,452,710$0false$0Yes (true)0.01000
MSK CLINIC PRACTICE
1275 YORK AVENYNY10065510616510HEALTH CARENYMEMRELATED$12,414,279$0false$0Yes (true)0.01000
RALPH LAUREN CTR
1275 YORK AVENYNY10065320577172HEALTH CARENYMEMRELATED$594,233$0false$0Yes (true)0.01000
MEM CLINICAL PHY
1275 YORK AVENYNY10065133278556HEALTH CARENYMEMRELATED$2,149,982$0false$0Yes (true)0.01000
MEM SOLID TUMOR GRP
1275 YORK AVENYNY10065133278578HEALTH CARENYMEMRELATED$43,910,792$0false$0Yes (true)0.01000
MEM DERMATOLOGY GRP
1275 YORK AVENYNY10065133278581HEALTH CARENYMEMRELATED$8,453,616$0false$0Yes (true)0.01000
MEM ENDOCRINE GRP
1275 YORK AVENYNY10065133278583HEALTH CARENYMEMRELATED$4,101,412$0false$0Yes (true)0.01000
GASTROENTEROLOGY
1275 YORK AVENYNY10065133278574HEALTH CARENYMEMRELATED$9,506,650$0false$0Yes (true)0.01000
MEM HEMATOLOGYLYMP
1275 YORK AVENYNY10065133278575HEALTH CARENYMEMRELATED$20,639,669$0false$0Yes (true)0.01000
MEM PULMONARY FUNC
1275 YORK AVENYNY10065133304834HEALTH CARENYMEMRELATED$4,761,790$0false$0Yes (true)0.01000
MEM CARDIOPULMONARY
1275 YORK AVENYNY10065133278552HEALTH CARENYMEMRELATED$5,076,373$0false$0Yes (true)0.01000
MSK RADIOLOGY GRP
1275 YORK AVENYNY10065133375559HEALTH CARENYMEMRELATED$96,548,292$0false$0Yes (true)0.01000
MEM NUCLEAR MED
1275 YORK AVENYNY10065133278580HEALTH CARENYMEMRELATED$9,916,032$0false$0Yes (true)0.01000
MSK HARRISON
1275 YORK AVENYNY10065300831483HEALTH CARENYMEMRELATED$22,077,888$0false$0Yes (true)0.01000
MSK BERGEN
1275 YORK AVENYNY10065611791803HEALTH CARENYMEMRELATED$13,253,556$0false$0Yes (true)0.01000
MSK MONMOUTH
1275 YORK AVENYNY10065300937486HEALTH CARENYMEMRELATED$19,879,355$0false$0Yes (true)0.01000
PANAKEIA ENERGY
10000 MEMORIAL DRHOUSTONTX77024800891961INVESTMENTDEMSKexcluded under 512-$20,298$320,393false-$3,650false0.99221
BTS LIQUIDATING LLC
1430 BROADWAYNYNY10018262602952INVESTMENTNYMSKexcluded under 512-$48,112$205,199false$0Yes (true)0.70000

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (3 entries)

Direct Controlling NADirectControllingNACdAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCdPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile Foreign CountryLegalDomicileForeignCountryCdBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtEntity TypeEntityTypeTxtShare Of Total IncomeShareOfTotalIncomeAmtShare Of EOY AssetsShareOfEOYAssetsAmtOwnershipOwnershipPctControlled OrganizationControlledOrganizationInd
CHARITABLE REMAINDER TRUSTS 142
N/A
TWO SIGMA US ALL CAP
89 NEXUS WAY CAMANA BAYGRAND CAYMANCJKY1-9007INVESTMENTCJMSKC-$7,243,017$56,167,5731.00000Yes (true)
AXAR OFFSHORE FUND LTD
PO BOX 309 UGLAND HOUSEGRAND CAYMANCJKY1-1104INVESTMENTCJMSKC$31,655,582$197,230,3270.79320Yes (true)
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgfalseGiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgYes (true)RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgYes (true)PerformOfServicesForOthOrgInd
Perform Of Services By Other OrgYes (true)PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesfalseSharingOfFacilitiesInd
Paid Employees SharingfalsePaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (7 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE
L$832,014,000COST
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
L$210,760,000COST
SKI REALTY INC
L$5,223,000COST
LOUIS V GERSTNER JR GRADUATE SCHOOL
L$19,000COST
MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE
M$16,964,000COST
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
M$9,660,000COST
SKI REALTY INC
K$8,089,000cost